[99mTc-hexamethyl-propyleneamine oxime cerebral perfusion SPECT in patients with cerebrovascular disease].
Jinnouchi
S
S
Hoshi
H
H
Yoshimura
H
H
Nagamachi
S
S
Ohnishi
T
T
Uwada
O
O
Futami
S
S
Watanabe
K
K
Nakano
S
S
Kinoshita
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000662:Amphetamines; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D020367:Iofetamine; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D014055:Tomography, Emission-Computed / Q000379:methods*; D014980:Xenon Radioisotopes
D000662:Amphetamines; D007457:Iodine Radioisotopes; D009942:Organometallic Compounds; D010091:Oximes; D014980:Xenon Radioisotopes; D019690:Technetium Tc 99m Exametazime; D020367:Iofetamine